Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Osteoporosis Therapy: Who Uses It and How Much Does It Cost?
Track:
Educational Sessions (CE)
Program Code: 270-L01
Date: Wednesday, December 9, 2009
Time: 4:00 PM to 5:00 PM EST
Location:
Palazzo E, Level 5
MEETING PLANNING ASSOCIATE:
Dr. Daniel Cobaugh, PharmD, FAACT, Senior Director for Research and Operations, ASHP Research and Education Foundation
PRESENTER(S):
Dr. Daniel Cobaugh, PharmD, FAACT, Senior Director for Research and Operations, ASHP Research and Education Foundation
Joel Farley, PhD, Assistant Professor of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy
Description
Planned in cooperation with the ASHP Research and Education Foundation
ACPE Activity #204-000-09-270-L01P
1.0 Contact Hour / Knowledge-based
Educational Content: General Interest
Moderator: Daniel Cobaugh, PharmD, FAACT, Senior Director for Research and Operations, ASHP Research and Education Foundation, Bethesda, MD
4:00 p.m. – 4:05 p.m.
Announcements
4:05 p.m. – 4:20 p.m.
Characteristics That Differentiate Anti-Osteoporosis Medication Users from Non-Users
Joel F. Farley, PhD, Assistant Professor of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill
4:20 p.m. – 4:35 p.m.
Strategies for Increased Clinician Monitoring for Osteoporosis
Joel F. Farley
4:35 p.m. – 4:50 p.m.
Strategies to Increase Patient Adherence to Anti-Osteoporosis Medications
Joel F. Farley
4:50 p.m. – 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
ACPE Activity #204-000-09-270-L01P
1.0 Contact Hour / Knowledge-based
Educational Content: General Interest
Moderator: Daniel Cobaugh, PharmD, FAACT, Senior Director for Research and Operations, ASHP Research and Education Foundation, Bethesda, MD
4:00 p.m. – 4:05 p.m.
Announcements
4:05 p.m. – 4:20 p.m.
Characteristics That Differentiate Anti-Osteoporosis Medication Users from Non-Users
Joel F. Farley, PhD, Assistant Professor of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill
4:20 p.m. – 4:35 p.m.
Strategies for Increased Clinician Monitoring for Osteoporosis
Joel F. Farley
4:35 p.m. – 4:50 p.m.
Strategies to Increase Patient Adherence to Anti-Osteoporosis Medications
Joel F. Farley
4:50 p.m. – 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
- Describe trends in the utilization of and spending for anti-osteoporosis medications in the U.S.
- Discuss characteristics that differentiate anti-osteoporosis medication users from non-users.
- Discuss strategies for increased clinician monitoring for osteoporosis.
- Discuss strategies to increase patient adherence to anti-osteoporosis medications.
This session is a part of:
Handout Online
